Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India

NAActive, not recruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

April 30, 2026

Conditions
HIV Infections
Interventions
BEHAVIORAL

Same-day ART initiation [experimental]

Participants assigned to same-day ART initiation will be offered standard, first-line ART on the day of trial enrollment. Participants, will be provided with focused counseling and instructions on where to follow-up for ongoing HIV care (either community-based HIV care or government-based HIV care, depending on randomization).

BEHAVIORAL

Standard ART initiation [usual care]

Participants randomized to standard ART initiation will not initiate ART on the day of trial enrollment, but only after linking to their assigned source of HIV care (either community-based HIV care or government-based HIV care, depending on randomization). In standard ART initiation, patients typically, complete an intake visit at the HIV clinic, with baseline laboratory testing, and return to the clinic approximately 2 weeks later to begin ART.

OTHER

Community-based HIV care [experimental]

Participants randomized to community-based HIV care will be referred to PWID-focused integrated care centers (ICCs) for ongoing HIV clinical management - a prototype of decentralized HIV care in India. ICCs will provide free HIV care that will adhere closely to Indian HIV treatment guidelines and, when relevant, to local HIV treatment standards.

OTHER

Government-based HIV care [usual care]

Participants randomized to government-based HIV care will be referred to government-based HIV clinics for ongoing HIV clinical management. Government-based clinics provide free HIV care that adheres closely to Indian HIV treatment guidelines

BEHAVIORAL

Enhanced adherence support [experimental]

Participants who i) experience virologic failure after 6 months in the study and ii) are randomized to enhanced adherence support will receive an intensive, tailored adherence intervention lasting a maximum of 6 months, with two components: 1) tracking and outreach, and 2) psychosocial support and navigation. These will aim to equip PWID with skills to independently manage their ART using motivational interviewing and strengths-based case management.

BEHAVIORAL

Routine adherence support [usual care]

Participants who i) experience virologic failure after 6 months in the study and ii) are randomized to routine adherence support will receive a guideline-based, HIV clinic-based adherence counselling intervention lasting a maximum of 6 months

Trial Locations (1)

Unknown

POINTER study -YRGCARE, New Delhi

All Listed Sponsors
collaborator

YR Gaitonde Centre for AIDS Research and Education

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER